GFAP and Parkinson disease: Additionally, we observed that DAPT decreased the number of GFAP+/BrdU+ cells, GFAP+ cells, DCX+/BrdU+ cells, and DCX+ cells in the SVZ of PD mice with Rbm24 overexpression (Figure 9D-I).